Linaclotide for Irritable Bowel Syndrome

Learn More From Dr. Satish Rao and William D. Chey on the AJG Podcast

AJG Co-Editor Dr. Paul Moayyedi talks with William D. Chey, MD, FACG and Satish Rao, MD, PhD, FACG about two randomized controlled trials on linaclotide in irritable bowel syndrome (IBS) published in the December issue of The American Journal of Gastroenterology. The phase 3 trials report that this new therapy significantly reduces constipation and abdominal pain associated with some kinds of IBS. (35:31)

Read the articles here and here.

Download from iTunes

Listen to the Podcast